A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
Recruiting · NCT05610085 · Registry updated 2026-06-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures | Hypoxia, Hypoxia, Brain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, brain disorder, brain hypoxia - ischemia, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, perinatal asphyxia, vascular disorder | Recruiting | Phase 2 | 2026-06-15 | NCT05610085 |
7 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Auckland City Hospital | Auckland | New Zealand | 8 |
| Capital and Coast District Health Board, Te Whatu Ora, Health New Zealand | Wellington | New Zealand | 1 |
| Middlemore Hospital | Auckland | New Zealand | 1 |
| University of California, San Diego | San Diego | United States | 29 |
| University of Minnesota | Minneapolis | United States | 325 |